SU3327
CAS No. 40045-50-9
SU3327( —— )
Catalog No. M24361 CAS No. 40045-50-9
SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 29 | In Stock |
|
5MG | 53 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 165 | In Stock |
|
50MG | 295 | In Stock |
|
100MG | 447 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU3327
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
-
DescriptionSU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
-
In Vitro——
-
In VivoAnimal Model:Male BKS.Cg-+Leprdb/+Leprdb/OlaHsd db/db mice (11-week-old ) injected with insulin Dosage:25 mg/kg Administration:Intraperitoneal injection Result:Resulted in a statistically significant reduction in blood glucose levels.
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
RecptorJNK|JNK-JIP interactions
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40045-50-9
-
Formula Weight261.3
-
Molecular FormulaC5H3N5O2S3
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (239.19 mM; Need ultrasonic)
-
SMILESNc1nnc(Sc2ncc([N+]([O-])=O)s2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De SK, et al. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. J Med Chem. 2009 Apr 9;52(7):1943-52.
molnova catalog
related products
-
[D-Arg1,D-Phe5,D-Trp...
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. Induces apoptosis and inhibits cancer cell growth in vitro.
-
SP600125
SP600125 is a potent, selective, reversible, ATP-competitive inhibitor of JNK with IC50 of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively.
-
d-Epigalbacin
d-Epigalbacin is a naturally occurring lignin. d-Epigalbacin is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively.